OptimizeRx Continues Coronavirus Conversation Series with Leaders of NextGen and Illumina
The ongoing conversations are part of OptimizeRx’s initiative to facilitate industry collaboration to help stop the spread of the virus. More than 400 members of the healthcare community have participated in the webinars which began last week.
Topic: Learning Together: Frontline HCP Communication During COVID-19
This webinar is designed to be a resource for HCPs and healthcare executives as we all learn together to navigate the COVID-19 pandemic. Approaching the topic from a variety of angles (providers, digital health messaging, and EHR communications), the panel will provide a valuable opportunity for participants to learn and engage with industry leaders in this discussion about designing solutions to combat the coronavirus.
The webinar is free and open to anyone in the industry and will provide an opportunity to communicate directly with the panelists.
Register today at www.optimizerx.com/webinars.
For more information about OptimizeRx’s webinar sessions, contact media relations at (754) 245-7070 or email@example.com.
The cloud-based solution supports patient adherence to medications and better healthcare outcomes with real-time access to financial assistance, prior authorization, education and critical clinical information.
Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other material risks.
Tel (248) 651-6568 x807
Media Relations Contact
Tel (754) 245-7070
Investor Relations Contact
Tel (949) 432-7557
Source: OptimizeRx Corporation